EK1 with dual Q1004E/N1006I mutation: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.

Yan, Fangfang; Gao, Feng

Yan, Fangfang; Gao, Feng.

Yan F; Department of Physics, School of Science, Tianjin University, Tianjin 300072, China.
Gao F; Department of Physics, School of Science, Tianjin University, Tianjin 300072, China; Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300072, China; SynBio Research Platform, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300072, China. Electronic address: fgao@tju.edu.cn.

J Infect ; 84(4): 579-613, 2022 04.

Article in English | MEDLINE | ID: covidwho-1783501

Subject(s)

COVID-19; SARS-CoV-2; Humans; Mutation; Protein Domains; SARS-CoV-2/genetics; Spike Glycoprotein, Coronavirus/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2021.12.022

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google